Cardiologists Put Their Oar Into Rocky SEAS and Debate the Results
This is a discussion on Cardiologists Put Their Oar Into Rocky SEAS and Debate the Results within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; While numerous experts say the results provide little new information and won't alter clinical practice, some see the data ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-25-2008, 02:34 PM
|
|||
|
|||
Cardiologists Put Their Oar Into Rocky SEAS and Debate the Results
While numerous experts say the results provide little new information and won't alter clinical practice, some see the data as positive for Vytorin, especially in light of the wealth of evidence showing the benefit of lowering LDL-cholesterol levels.
Heartwire More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Vytorin Misses Primary End Point in SEAS Study | industry_news | Other Clinical Pharmacy News | 0 | 07-22-2008 02:14 PM |
| Screening for Risk Factors or Detecting Disease? DEBATE Divides the CV Community | industry_news | Other Clinical Pharmacy News | 0 | 07-22-2008 02:14 PM |
| Amgen releases positive denosumab results | industry_news | Biotechnology News | 0 | 07-14-2008 03:25 PM |
| Alzheimer's vaccine results boost Elan, Wyeth | industry_news | Biotechnology News | 0 | 06-17-2008 07:00 PM |
| Pfizer halts Phase III cancer trial on poor results | industry_news | Biotechnology News | 0 | 04-02-2008 02:39 PM |
© 2008 DrugManagementForum™ powered by |
 |